Medtronic plc
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Geoffrey Straub Martha
- Full Time Employees
- 95,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Building Two, Parkmore Business Park West Galway GA Ireland H91 4K49
- IPO Date
- May 2, 1973
- CIK
- 0001613103
- Website
- medtronic.com
- Similar Companies
- Business
- Medtronic plc (NYSE: MDT) develops, manufactures, and markets a wide range of medical devices and therapies for the treatment of chronic diseases worldwide. The company offers products across four main segments: cardiovascular (including pacemakers, defibrillators, heart valves, and coronary stents under brands such as Evera, Protecta, and CoreValve); medical surgical (featuring surgical navigation systems, endoscopic tools, and stapling devices like Hugo RAS and Valiant NaviCore); neuroscience (encompassing spinal cord stimulators, deep brain stimulation systems, and intrathecal drug delivery pumps such as Incepta and SynchroMed II); and diabetes (primarily continuous glucose monitoring systems, insulin pumps, and related software through the MiniMed and Guardian brands). Medtronic provides services including patient management software, remote monitoring platforms, and clinical decision support tools to healthcare providers, hospitals, clinics, and patients globally. Founded in 1949 and headquartered in Dublin, Ireland, with principal executive offices in Minneapolis, Minnesota, USA, Medtronic operates in more than 150 countries, serving markets in North America, Europe, Asia-Pacific, Latin America, and the Middle East through direct sales forces, distributors, and subsidiaries. The company targets physicians, hospitals, ambulatory surgery centers, and home care settings, with a focus on minimally invasive therapies and digital health solutions. Key subsidiaries include Covidien (acquired in 2015 for surgical and patient monitoring products) and Intersect ENT (recently integrated for sinus implants). In the past 1-2 years, Medtronic has pursued strategic expansions including the FDA approval and U.S. launch of the Hugo robotic-assisted surgery (RAS) system in 2024 for soft tissue indications, building on its European CE Mark; a multi-year collaboration with NVIDIA announced in 2024 to advance AI-enabled therapies using Medtronic's Gigamon data platform; and the acquisition of Mazor Robotics in 2018 followed by ongoing enhancements to its spinal robotics portfolio with the Mazor X Stealth Edition. The company completed a $4.1 billion acquisition of Covidien assets integration and reported expansions in diabetes care via the Simplera Sync sensor FDA clearance in 2024. Medtronic also announced organizational realignments in 2025 to streamline its four operating units amid portfolio optimization efforts.
Baldwin Investment Management LLC Makes New Investment in Medtronic PLC $MDT
Atria Investments Inc Has $12.24 Million Position in Medtronic PLC $MDT
Asset Management One Co. Ltd. Cuts Stock Holdings in Medtronic PLC $MDT
Wall Street Bulls Look Optimistic About Medtronic (MDT): Should You Buy?
Ballast Inc. Acquires 7,320 Shares of Medtronic PLC $MDT
24,967 Shares in Medtronic PLC $MDT Acquired by First Bank & Trust
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
Medtronic: Buy This Undervalued Dividend Aristocrat Before The Market Catches On
We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.
Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?
I've Got Royalty on the Brain
180 Wealth Advisors LLC Lowers Holdings in Medtronic PLC $MDT
Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias
I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026
Retirees: 3 High-Yielding Dividend Stocks to Buy for Long-Term Stability and Recurring Cash Flow
Medtronic (MDT) Laps the Stock Market: Here's Why
Avidity Partners Management LP Sells 7,600 Shares of Medtronic PLC $MDT
Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It
This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know